Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib vs Imatinib in Newly Diagnosed CP Ph+ CML
NCT00574873Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 29
01
Overview
A Phase 3 trial of bosutinib in chronic myeloid leukemia (CML), sponsored by Pfizer. Started Feb 2008; status: completed.
02
Drugs
bosutinib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00574873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574873.